Bristol-Myers Squibb stock falls on lung cancer drug study result - MarketWatch

Bristol-Myers Squibb stock falls on lung cancer drug study result  MarketWatch

Bristol-Myers Squibb Co. fell in the extended session Wednesday after the drug maker said its lung cancer drug did not achieve one of its goals in a late-stage ...